FDA approves MSD’s Keytruda to treat head and neck cancer
Pharmaceutical Technology
JUNE 16, 2025
Keytruda is designed to enhance the immune system’s ability to detect and combat tumour cells. GlobalData Strategic Intelligence US Tariffs are shifting - will you react or anticipate? Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
52 
Let's personalize your content